Phase II study of docetaxel plus epirubicin versus docetaxel plus cisplatin as first-line chemotherapy for treatment of advanced breast cancer (CHN TAX-618)Y J Wang,Qiang Fu,Qing Wu,F X Su,L Z Zhou,Z B Ye,J Q Yangmag(2006)引用 23|浏览2暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要